'Spinal amaurosis' (1841). On the early contribution of Edward Hocken to the concept of neuromyelitis optica

Journal of Neurology

Volumn 261, Issue 2, 2014, Pages 400-404

  Jarius, S ^a   Wildemann, B ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Aquaporin 4 antibodies; Devic's disease; Devic's syndrome; History of medicine; Multiple sclerosis; Neuromyelitis optica; Optic neuritis; Transverse myelitis

Indexed keywords

ARTICLE; BLINDNESS; HUMAN; MEDICAL HISTORY; MEDICAL LITERATURE; MYELITIS; MYELOOPTIC NEUROPATHY; PRIORITY JOURNAL; PUBLICATION; SPINAL AMAUROSIS; SPINAL CORD DISEASE; SYMPTOMATOLOGY;

BLINDNESS; HISTORY, 19TH CENTURY; HUMANS; NEUROMYELITIS OPTICA; SPINAL CORD; SPINAL CORD DISEASES; TERMINOLOGY AS TOPIC;

EID: 84897931262     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-013-7210-x     Document Type: Article

References (48)

1. Ackerknecht EH (1974) The history of the discovery of the vegetative (autonamic) nervous system. Med Hist 18:1-8
2. Akman-Demir G, Tuzun E, Waters P, Icoz S, Kurtuncu M, Jarius S, Yapici Z, Mutlu M, Yesilot N, Vincent A, Eraksoy M (2010) Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients. J Neurol 258:464-470
3. Allbutt TC (1870) On the ophthalmoscopic signs of spinal disease. Lancet 95:76-78
4. Anonymous (1846) The London medical directory. John Churchill, London
5. Chambers WF (1846) An address delievered before the Royal Medical and Chirurgical Society of London, at the Anniversary Meeting, held on Monday, March 2nd. Lancet 47:291-294
6. Chang KH, Lyu RK, Chen CM, Wu YR, Chang HS, Huang CC, Kuo HC, Chu CC, Hsu WC, Ro LS (2013) Distinct features between longitudinally extensive transverse myelitis presenting with and without anti-aquaporin 4 antibodies. Mult Scler 19:299-307
7. Devic E (1895) Myélite aiguë dorso-lombaire avec névrite optique-Autopsie. In: Congrès français de médecine (Premiere Session; Lyon, 1894; Procès-verbaux, mémoires et discussions; Publiés par M. le Dr L. Bard). Asselin et Houzeau, Louis Savy, Lyon, pp 434-439
8. Erb W (1880) Ueber das Zusammenvorkommen von Neuritis optica und Myelitis subacuta. Archiv für Psychiatrie und Nervenkrankheiten 10:146-157
9. Gault F (1894) De la neuromyélite optique aiguë. Thése. Faculté de Médecine et de Pharmacie, Lyon
10. Hocken E (1841) Illustrations of the pathology and treatment of the amauroses. Amaurosis from affections of the spinal cord or its membranes. London Medical Gazette 707. XXVIII. New Series. Vol. II. For the session 1840-41:499-504
11. Hocken EO (1844) A complete condensed practical treatise on ophthalmic medicine. Part 1. Samuel Highley, London
12. Hocken EO (1841-42) Illustrations of the pathology, diagnosis, and treatment of ophthalmic affections. Lancet 37:349-352; 636-639
13. Hocken EO (1842) Illustrations of the pathology, diagnosis, and treatment of ophthalmic affections. Lancet 38:81-84
14. Hocken EO (1841) Illustrations on the pathology and treatment of amaurosis. Lancet 36:38-42; 153-157; 223-225; 357-361; 470-474; 534-537; 713-716; 775-779; 916-919
15. Hocken EO (1841) Illustrations on the pathology and treatment of amaurosis. Part IV. Amaurosis from affections of the spinal cord or its membranes. Lancet 36:470-474
16. Hocken EO (1841) On the diagnosis, pathology, and treatment of amaurosis. Lancet 36:7-10
17. Hocken EO (1842) A treatise on amaurosis and amaurotic affections. A. Waldie, Philadeliphia
18. Hocken EO (1840) A treatise on amaurosis and amaurotic affections. S. Highley, London
19. Hunter RA, Thornton JL (1958) Edward Octavius Hocken (1820-1845); life and writings of a forgotten man. Med Hist 2:57-61
20. Jarius S, Jacobi C, de Seze J, Zephir H, Paul F, Franciotta D, Rommer P, Mader S, Kleiter I, Reindl M, Akman-Demir G, Seifert-Held T, Kristoferitsch W, Melms A, Wandinger KP, Wildemann B (2011) Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders. Mult Scler 17:1067-1073
21. Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R, Vincent A, Wildemann B (2008) Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 4:202-214 (Pubitemid 351516748)
22. Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C, Kleiter I, Kleinschnitz C, Berthele A, Brettschneider J, Hellwig K, Hemmer B, Linker RA, Lauda F, Mayer CA, Tumani H, Melms A, Trebst C, Stangel M, Marziniak M, Hoffmann F, Schippling S, Faiss JH, Neuhaus O, Ettrich B, Zentner C, Guthke K, Hofstadt-van Oy U, Reuss R, Pellkofer H, Ziemann U, Kern P, Wandinger KP, Then Bergh F, Boettcher T, Langel S, Liebetrau M, Rommer PS, Niehaus S, Munch C, Winkelmann A, Zettl UK, Metz I, Veauthier C, Sieb JP, Wilke C, Hartung HP, Aktas O, Paul F (2012) Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflamm 9:14
23. Jarius S, Wandinger KP, Borowski K, Stoecker W, Wildemann B (2012) Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease: case report and review of the literature. Clin Neurol Neurosurg 114:331-335
24. Jarius S, Wildemann B (2010) AQP4 antibodies in neuromyelitis optica: pathogenic and diagnostic relevance. Nat Rev Neurol 6:383-392
25. Jarius S, Wildemann B (2013) Aquaporin-4 antibodies (NMOIgG) as a serological marker of neuromyelitis optica: a critical review of the literature. Brain Pathol 23:661-683
26. Jarius S, Wildemann B (2012) The case of the Marquis de Causan (1804): an early account of visual loss associated with spinal cord inflammation. J Neurol 259:1354-1357
27. Jarius S, Wildemann B (2012) An early British case of neuromyelitis optica (1850). BMJ 345:e6430
28. Jarius S, Wildemann B (2011) An early case of neuromyelitis optica: on a forgotten report by Jacob Lockhart Clarke, FRS. Mult Scler 17:1384-1386
29. Jarius S, Wildemann B (2013) The history of neuromyelitis optica. J Neuroinflamm 10:8
30. Jarius S, Wildemann B (2012) 'Noteomielite' accompanied by acute amaurosis (1844). An early case of neuromyelitis optica. J Neurol Sci 313:182-184
31. Jarius S, Wildemann B (2013) On the contribution of Thomas Clifford Allbutt, F.R.S., to the early history of neuromyelitis optica. J Neurol 260:100-104
32. Kitley J, Woodhall M, Waters P, Leite MI, Devenney E, Craig J, Palace J, Vincent A (2012) Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology 79:1273-1277
33. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473-477 (Pubitemid 41186945)
34. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106-2112 (Pubitemid 39626806)
35. Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K, Lutterotti A, Jarius S, Di Pauli F, Kuenz B, Ehling R, Hegen H, Deisenhammer F, Aboul-Enein F, Storch MK, Koson P, Drulovic J, Kristoferitsch W, Berger T, Reindl M (2011) Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflamm 8:184
36. Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Zephir H, Moder K, Weinshenker BG (2008) Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 65:78-83
37. Portal A (1804) Cours d'anatomie médicale, ou élé ments de l'anatomie de l'homme. Avec des remarques physiologiques et pathologiques, et les résultats de l'observation sur le siége et la nature des maladies, d'après l'ouverture des corps Baudoin, Laport, Bertrand, Paris
38. Rostasy K, Mader S, Hennes E, Schanda K, Gredler V, Guenther A, Blaschek A, Korenke C, Pritsch M, Pohl D, Maier O, Kuchukhidze G, Brunner-Krainz M, Berger T, Reindl M (2012) Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Mult Scler 19:1052-1059
39. Sellner J, Boggild M, Clanet M, Hintzen RQ, Illes Z, Montalban X, Du Pasquier RA, Polman CH, Sorensen PS, Hemmer B (2010) EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol 17:1019-1032
40. Sellner J, Hemmer B, Muhlau M (2010) The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes. J Autoimmun 34:371-379
41. Trebst C, Jarius S, Berthele A, Paul F, Schippling S, Wildemann B, Borisow N, Kleiter I, Aktas O, Kümpfel T; Neuromyelitis Optica Study Group (NEMOS) (2013) Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol 261:1-16
42. Wandinger KP, Stangel M, Witte T, Venables P, Charles P, Jarius S, Wildemann B, Probst C, Iking-Konert C, Schneider M (2010) Autoantibodies against aquaporin-4 in patients with neuropsychiatric systemic lupus erythematosus and primary Sjogren's syndrome. Arthritis Rheum 62:1198-1200
43. Wharton-Jones T (1869) Failure of sight from railway and other injuries of the spine and head. With a physiological and pathological disquisition into the influence of the vaso-motor nerves on the circulation of the blood in the extreme vessels. Bradbury, Evans, and Co., London
44. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53:1107-1114 (Pubitemid 29442132)
45. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6:805-815 (Pubitemid 47238676)
46. Yang Y, Huang DH, Wu WP, Wu L, Chen LF, Wu Q (2013) The role of aquaporin-4 antibodies in Chinese patients with neuromyelitis optica. J Clin Neurosci 20:94-98
47. Yoshimura S, Isobe N, Matsushita T, Yonekawa T, Masaki K, Sato S, Kawano Y, Kira J (2013) Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status. J Neurol Neurosurg Psychiatry 84:29-34
48. Závada J, Nytrová P, Wandinger KP, Jarius S, Svobodová R, Probst C, Peterová V, Tegzová D, Pavelka K, Vencovský J (2013) Seroprevalence and specificity of NMO-IgG (anti-aquaporin 4 antibodies) in patients with neuropsychiatric systemic lupus erythematosus. Rheumatol Int 33:259-263